Advertisement

Topics

Companies Related to "Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice" [Most Relevant Company Matches] RSS

03:02 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice" found in our extensive corporate database of over 50,000 company records.

Showing "Therapeutic Effectiveness Vardenafil Patients With Erectile Dysfunction Metabolic" Companies 1–25 of 5,400+

Relevant

NanoCyte Inc

NanoCyte Inc., Founded in August 2000, is a biotechnology start-up, developing an Immediate Release (IR) transdermal drug delivery platform technology. NanoCyte Ltd., a fully owned subsidiary is located in Israel, by the Sea of Galilee.NanoCyte is leveraging marine extracted nano-injectors formulated with therapeutic compounds. The outcome is a topical formulation, penetrating the skin within a fr...


NuMale Medical Center

NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation and low sex drive, utilizing a wide range of the most highly respected, FDA-approved treatments. Founded and led b...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...


Cyrano Therapeutics, Inc.

Cyrano Therapeutics, Inc. is a United States based pharmaceutical company developing therapeutic solutions for olfactory dysfunction, a condition that limits the ability to taste and smell in more than 14 million people in the USA and up to 12% of the population in China. There are also important medical consequences to this condition, as 30% of people wit...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...

Makefield Therapeutics, Inc.

Makefield Therapeutics, Inc., founded in July 2009, is a privately held therapeutics company with two development programs addressing large market opportunities in anti-infectives and the treatment of erectile dysfunction. Both programs are based on an innovative nanoparticle drug delivery platform with the potential to generate a pipeline of additional no...

Akrimax Pharmaceuticals, LLC

Akrimax Pharmaceuticals, LLC is a privately-held, fully-integrated specialty pharmaceutical company that acquires markets and develops products in the areas of cardiology and metabolic conditions. Based in Cranford, NJ, Akrimax is committed to addressing the challenges of patients head-on by building strong relationships with customers and therapeutic thou...

American Medical Systems, Inc.

American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the ...

Shionogi & Co., Ltd.

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain and Metabolic Syndrome. The Company has provided such innovative medicines as Crestor and Dori...

American Medical Systems Holdings, Inc.

American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect s...

Shionogi Pharma, Inc.

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Company has provided such innovative medicines as Crestor and Dor...

American Medical Systems

Through the Power of Our People, and in accordance with the AdvaMed Code of Ethics, we continue to develop new therapies to restore bodily functions and to enable people to regain control of their lives. These therapies are often inspired by the urologists, gynecologists and urogynecologists who choose AMS as their solutions partner ... truly the Surgeon's Choice. Several of our treatments are so...

AMS

AMS was founded in 1972 by Robert Buuck, Gerald Timm, Ph.D., William Bradley, M.D. and F. Brantley Scott, M.D. That year, Dr. Scott implanted the first urinary sphincter for incontinence.Company engineers then developed the first inflatable penile prosthesis for erectile dysfunction. In its early days, AMS also built the foundation for its strong physician relationships by developing surgical semi...

Metabolic Solutions Development Company

Metabolic Solutions Development Company (www.msdrx.com), based in Kalamazoo, Mich., is developing innovative therapeutics using a different pharmacological path to treat type 2 diabetes and related metabolic diseases. This new approach seeks to improve the efficacy of treatment and free patients from the adverse side effects of current treatments, including edema and weight gain.

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Boston Medical Group

For over a decade, Boston Medical Group’s network of independent physicians has provided men with solutions to treat sexual health issues such as erectile dysfunction and premature ejaculation. The physicians provide therapies and treatment programs that can help men regain their sexual health and function, including those who are unable to take syste...

Sagene Pharmaceuticals

Sagene Pharmaceuticals is a biopharmaceutical company developing novel applications for combinations of FDA-approved drugs to treat diseases associated with aging. Sagene has shown that selective MAO-B inhibitors, specifically selegiline (l-deprenyl), can reduce side effects and enhance efficacy in combination with current treatments for erectile dy...

NuSirt Sciences, Inc.

NuSirt Sciences, Inc., headquartered in Nashville, is dedicated to improving the lives of people living with chronic metabolic diseases. The company has a unique technology platform that uses a patented combination of leucine, an essential amino acid, and existing human medicines targeted at diseases that may be addressed by activating sirtuin pathways. In...

Shionogi Inc.

Shionogi Inc. is a US-based company of Shionogi & Co., Ltd. Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Compa...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

DiObex

DiObex, Inc., a clinical-stage company based in San Francisco, is developing unique, first-in-class therapies for the critically under-served metabolic disease market. Our pipeline products address the markets for the treatment of type 1 diabetes, type 2 diabetes and its co-morbidities such as hypertension, dyslipidemia and visceral adiposity (often referred to collectively as “metabolic syndrom...

ERYtech Pharma

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of erythrocytes. The company addresses serious pathologies, orphan indications or sub-populations of patients, particularly in the fields of haematology, cancer and metabolic diseases. ...

VIVUS, Inc.

VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. QNEXA is also in phase 2 clinical development for the tr...

Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. Ritter is advancing human gut health research by exploring the metabolic capacity of gut microbiota and translating the functionality of these microbiome modulators into safe and effectiv...

METabolic EXplorer S.A.

METabolic EXplorer develops and applies cutting edge tools of biotechnology to design new biosynthetic pathways for the efficient and cost-effective production of valuable chemicals.METabolic EXplorer provides the chemical and life science industry with cost-effective innovative solutions for the manufacturing of their chemicals by fermentation.METabolic EXplorer creates new whole-cell biotransfor...


More From BioPortfolio on "Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks